Staphylococcus haemolyticus: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
| Line 15: | Line 15: | ||
''S. haemolyticus'' is resistant to multiple antimicrobial agents.<ref name=Froggatt_1989>{{cite journal | author=Froggatt JW, Johnston JL, Galetto DW, Archer GL | title=Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus | journal=Antimicrob Agents Chemother | year=1989 | pages=460-6 | volume=33 | issue=4 | id={{PMID|2729941}} [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172460 fulltext] }}</ref> Resistance to [[vancomycin]] has been recorded, and this is a cause for concern because such resistance could be acquired by other, more [[pathogen|pathogenic]] staphylococci.<ref Gemmell_2004>{{cite journal | author=Gemmell CG | title=Glycopeptide resistance in ''Staphylococcus aureus'': is it a real threat? | journal=J Infect Chemother | year=2004 | pages=69-75 | volume=10 | issue=2 | id={{PMID|15160298}} }}</ref> | ''S. haemolyticus'' is resistant to multiple antimicrobial agents.<ref name=Froggatt_1989>{{cite journal | author=Froggatt JW, Johnston JL, Galetto DW, Archer GL | title=Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus | journal=Antimicrob Agents Chemother | year=1989 | pages=460-6 | volume=33 | issue=4 | id={{PMID|2729941}} [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172460 fulltext] }}</ref> Resistance to [[vancomycin]] has been recorded, and this is a cause for concern because such resistance could be acquired by other, more [[pathogen|pathogenic]] staphylococci.<ref Gemmell_2004>{{cite journal | author=Gemmell CG | title=Glycopeptide resistance in ''Staphylococcus aureus'': is it a real threat? | journal=J Infect Chemother | year=2004 | pages=69-75 | volume=10 | issue=2 | id={{PMID|15160298}} }}</ref> | ||
==Treatment== | |||
===Antimicrobial regimen=== | |||
==References== | ==References== | ||
| Line 21: | Line 24: | ||
[[Category:Gram positive bacteria]] | [[Category:Gram positive bacteria]] | ||
[[Category:Staphylococcaceae]] | [[Category:Staphylococcaceae]] | ||
[[Category:Infectious Disease Project]] | |||
{{med-stub}} | {{med-stub}} | ||
{{bacteria-stub}} | {{bacteria-stub}} | ||
Revision as of 15:01, 23 July 2015
| Staphylococcus haemolyticus | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scientific classification | ||||||||||||||
| ||||||||||||||
| Binomial name | ||||||||||||||
| Staphylococcus haemolyticus Schleifer & Kloos 1975 |
Staphylococcus haemolyticus is a species of bacterium belonging to the genus Staphylococcus. It is a Gram positive coccus, coagulase negative, and catalase positive. Frequently found as a commensal organism on the skin of humans and animals, S. haemolyticus occurs infrequently as a cause of soft-tissue infections, usually in immunocompromised patients. [1]
S. haemolyticus is resistant to multiple antimicrobial agents.[2] Resistance to vancomycin has been recorded, and this is a cause for concern because such resistance could be acquired by other, more pathogenic staphylococci.
Treatment
Antimicrobial regimen
References
- ↑ Rolston KVI, Bodey GP. (2003). Infections in Patients with Cancer. In: Cancer Medicine (Kufe DW et al, eds.) (6th ed. ed.). BC Decker. (via NCBI Bookshelf) ISBN 0-9631172-1-1.
- ↑ Froggatt JW, Johnston JL, Galetto DW, Archer GL (1989). "Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus". Antimicrob Agents Chemother. 33 (4): 460–6. PMID 2729941 fulltext.